WS Management’s Teladoc Health TDOC Stock Holding History

WS Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,500	Closed	-$509K	–	86
2022 Q2	$482K	Buy	+14,500	New	+$616K	0.04%	69

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

WS Management's TDOC Position: Q3 2022 in Review

WS Management sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 14,500 shares — an estimated $509K sold.

WS Management first reported a position in TDOC in Q2 2022 and held it in 1 quarter. The position peaked at $482K in Q2 2022. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

WS Management reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
WS Management sold 14,500 Teladoc Health shares in Q3 2022, an estimated $509K.
WS Management first reported a position in Teladoc Health in Q2 2022 and held it in 1 quarter.
WS Management's Teladoc Health position peaked at $482K in Q2 2022.
482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on WS Management's 13F filing for Q3 2022, filed 14 Nov 2022.